Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison T Stopeck

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Visual Computing for Industry, Biomedicine, and Art|October 11, 2022
Two fully automated data-driven 3D whole-breast segmentation strategies in MRI for MR-based breast density using image registration and U-Net with a focus on reproducibilityJia Ying, Renee Cattell, Tianyun Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase InhibitorsPatricia A Thompson, Chuan Huang, Jie Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancerHope S Rugo, Alison T Stopeck, Anil A Joy, et al.
Blood|March 9, 2007
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801Daniel J DeAngelo, Daohai Yu, Jeffrey L Johnson, et al.
Breast Cancer Research and Treatment|December 27, 2011
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancerHope S Rugo, A Jo Chien, Sandra X Franco, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 10, 2018
Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRIJie Ding, Alison T Stopeck, Yi Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation studyShanu Modi, Alison T Stopeck, Michael S Gordon, et al.
Leukemia Research|May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaAnne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind studyAlison T Stopeck, Allan Lipton, Jean-Jacques Body, et al.
Magnetic Resonance Imaging|August 19, 2015
Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver MetastasisRenu M Stephen, Abhinav K Jha, Denise J Roe, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Visual Computing for Industry, Biomedicine, and Art|October 11, 2022
Two fully automated data-driven 3D whole-breast segmentation strategies in MRI for MR-based breast density using image registration and U-Net with a focus on reproducibilityJia Ying, Renee Cattell, Tianyun Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase InhibitorsPatricia A Thompson, Chuan Huang, Jie Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancerHope S Rugo, Alison T Stopeck, Anil A Joy, et al.
Blood|March 9, 2007
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801Daniel J DeAngelo, Daohai Yu, Jeffrey L Johnson, et al.
Breast Cancer Research and Treatment|December 27, 2011
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancerHope S Rugo, A Jo Chien, Sandra X Franco, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 10, 2018
Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRIJie Ding, Alison T Stopeck, Yi Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation studyShanu Modi, Alison T Stopeck, Michael S Gordon, et al.
Leukemia Research|May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaAnne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind studyAlison T Stopeck, Allan Lipton, Jean-Jacques Body, et al.
Magnetic Resonance Imaging|August 19, 2015
Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver MetastasisRenu M Stephen, Abhinav K Jha, Denise J Roe, et al.
Pageof 5